Feb 6 (Reuters) - PROBI:
* LARGEST CLINICAL TRIAL CONFIRMS THE IMMUNE ENHANCING IMPACT OF PROBI DEFENDUM® AND SHEDS NEW LIGHT ON THE MECHANISM
* RESULTS FROM STUDY SHOW THAT PROBI DEFENDUM® SIGNIFICANTLY DECREASES RECURRENT COMMON COLDS Source text for Eikon: Further company coverage: (Gdynia Newsroom)